A randomized trial of plasma volume expansion in hypertensive disorders of pregnancy: influence on the pulsatility indices of the fetal umbilical artery and middle cerebral artery

Am J Obstet Gynecol. 2005 Jan;192(1):233-9. doi: 10.1016/j.ajog.2004.06.061.

Abstract

Objective: The purpose of this study was to investigate the effect of plasma volume expansion on the pulsatility indices of the fetal umbilical and middle cerebral arteries.

Study design: Two hundred sixteen patients with severe preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, eclampsia, hypertension-related fetal growth restriction, and gestational ages between 24 and 34 completed weeks of gestation were assigned randomly for temporizing treatment with plasma volume expansion (n = 111 patients; 250 mL hydroxyethyl starch 6% twice daily in 4 hours, and NaCl 0.9% between doses of hydroxyethyl starch and with intravenous medication) or without plasma volume expansion (n = 105; only NaCl 0.9% when necessary with medication). Measurements of the pulsatility index of the umbilical and middle cerebral arteries were performed at admission, after 16 to 48 hours, 60 to 120 hours, and 7 to 11 days.

Results: Median gestational age was 30 weeks in both groups. Infused volumes of plasma volume expansion in the treatment group (total median, 813 mL/d) were associated with a significant decrease of hemoglobin concentration. Changes from baseline measurements of the umbilical and middle cerebral arteries were not different between the groups nor within subgroups during the first 7 to 11 days.

Conclusion: Plasma volume expansion did not influence the pulsatility indices of the umbilical and middle cerebral arteries.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Volume / drug effects
  • Blood Volume / physiology
  • Female
  • Fetus / blood supply*
  • HELLP Syndrome / drug therapy*
  • HELLP Syndrome / physiopathology
  • Humans
  • Hydroxyethyl Starch Derivatives / administration & dosage
  • Hydroxyethyl Starch Derivatives / therapeutic use*
  • Infusions, Intravenous
  • Middle Cerebral Artery / drug effects
  • Middle Cerebral Artery / physiology
  • Plasma Substitutes / administration & dosage
  • Plasma Substitutes / therapeutic use*
  • Pregnancy
  • Pulsatile Flow / drug effects
  • Regional Blood Flow / drug effects
  • Sodium Chloride / administration & dosage
  • Sodium Chloride / therapeutic use*
  • Treatment Outcome
  • Ultrasonography, Doppler
  • Ultrasonography, Prenatal
  • Umbilical Arteries / drug effects
  • Umbilical Arteries / physiology

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Sodium Chloride